top of page


Alaunos acquires Velaris Therapeutics alongside $350 million financing for pulmonary hypertension pipeline
Alaunos Therapeutics has acquired Velaris Therapeutics in a stock-for-stock transaction supported by a separate $350 million financing to advance pulmonary hypertension treatments.

nuaxia
Oct 152 min read


Horizon Space Acquisition signs $2 billion business combination agreement with ArcheNova Biotech
Horizon Space Acquisition I Corp. has agreed to combine with ArcheNova Biotech in a transaction valuing the clinical-stage biotechnology company at approximately $2 billion.

nuaxia
Oct 142 min read


Werewolf Therapeutics and Ambros agree all-stock merger to advance Phase III CRPS therapy
The combination will create a Nasdaq-listed Ambros Therapeutics focused on neridronate, backed by a concurrent $150 million private placement expected to fund the programme through Phase III results and a planned FDA submission.

nuaxia
Aug 243 min read


Slate Medicines to merge with Fulcrum Therapeutics and raise $245 million to advance migraine pipeline
The reverse-merger transaction gives privately held Slate a Nasdaq listing and additional capital to advance its anti-PACAP migraine portfolio, led by clinical-stage monoclonal antibody SLTE-1009.

nuaxia
Aug 193 min read


UK Biotech Financing Hits Five-Year High as Venture Capital Momentum Accelerates
Strong private investment signals renewed confidence in the UK life sciences sector, but public markets remain a challenge.

nuaxia
Jul 203 min read
bottom of page